483 Response Premier Clinical Research Nov 2017

Mark Babbitt FDA$119.00 - Available Now

FDA investigators audited the Premier Clinical Research - Spokane, WA, United States facility and issued inspectional observation (via FDA 483) on 29 Nov 2017.

Product details

  • Category:
  • Inspection end: 29 Nov 2017
  • Location: Spokane, United States
  • FEI: 3011321193
Add To Cart